543363 — PREVEST DENPRO Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual income statement for PREVEST DENPRO, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	193	228	376	499	564
Cost of Revenue
Gross Profit	128	158	278	372	425
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	159	182	236	309	379
Operating Profit	33.4	45.7	140	189	186
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	36.9	61.4	161	210	214
Provision for Income Taxes
Net Income After Taxes	29	51.2	116	157	161
Net Income Before Extraordinary Items
Net Income	29	51.2	116	157	161
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	29	51.2	116	157	161
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.42	4.26	9.64	13.1	13.4
Dividends per Share